James E. Davis has been the CEO of Quest Diagnostics since November 1, 2022, taking over from Stephen H. Rusckowski, which was a significant leadership change for the company after more than a decade. He moved into this role after...
James E. Davis has been the CEO of Quest Diagnostics since November 1, 2022, taking over from Stephen H. Rusckowski, which was a significant leadership change for the company after more than a decade. He moved into this role after previously serving as Executive Vice President of General Diagnostics. During his tenure, the company experienced impressive performance metrics, including a notable growth in revenues tied to his strategic focus on operational efficiency and medical quality. Looking at his compensation, in 2023, he earned a total of about $1.17 million in salary, but when you include bonuses and other compensation related to performance, it brought his total to over $12.67 million. This reflects a strong link between his pay and how well the company does — a policy intended to motivate and align management with shareholder success. Davis has been quite active in trading Quest Diagnostics stock, with significant transactions reported totaling over $20 million in 2024 alone. This shows his confidence in the company’s future and suggests he has a lot of skin in the game. He’s not just about numbers, though; under his leadership, Quest Diagnostics has been embracing new challenges while keeping a keen eye on financial and operational targets.